We did not observe the impact of BMI > 25 kg/m2, smoking, alcohol consumption, duration of diabetes, the type of therapy, i.e., multiple dose injection (MDI) or continuous subcutaneous insulin infusion (CCII), or the use of glucose monitoring systems on the results of the scales. This evidence concerns the gene INS and diabetes mellitus.